Skip to main content

Table 1 Summary of collected patient data presented as median values and (interquartile ranges)

From: Radioiodine treatment outcome by dosimetric parameters and renal function in hyperthyroidism

Parameter

All diagnoses

Graves’ disease

Toxic multinodular goitre

Solitary toxic adenoma

No. of patients

904

335

394

175

Age [years]

66 (52 75)

53 (44 67)

72 (64 78)

66 (55 75)

Females [%]

84

82

85

84

Uptake at 24 h [%]

37 (28 53)

57 (45 65)

31 (25 38)

31 (25 38)

Target massa [g]

45 (30 55)

50 (45 55)

45 (35 55)

25 (20 30)

Absorbed dose [Gy]

-

123 (120 125)

176 (130 202)

293 (237 305)

Activity [MBq]

-

447 (370 756)

805 (709 825)

805 (712 828)

Effective half-lifeb [d]

6.4 (5.8 7.2)

6.2 (5.4 6.9)

6.9 (6.3 7.4)

6.3 (5.7 6.8)

eGFR [ml/min/1.7 m2]

75 (63 89)

83 (70 90)

71 (58 81)

76 (66 87)

  1. aMass of hyperactive thyroid tissue
  2. bDetermined for 392 patients who underwent uptake measurements at 24 h and 7 d post administration of tracer amounts of iodine-131